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Abstract: Varicella-Zoster virus (VZV) is a human herpesvirus that causes varicella (chickenpox) as a
primary infection, and, following a variable period of ganglionic latency in neurons, it reactivates to
cause herpes zoster (shingles). An analysis of VZV infection in cultures of neural cells, in particular
when these have been obtained from induced pluripotent stem cells (iPSCs) or neural stem cells
consisting of highly purified neuronal cultures, has revealed much data that may be of neurobiological
significance. Early studies of VZV infection of mature cultured neural cells were mainly descriptive,
but more recent studies in homogeneous neural stem cell cultures have used both neuronal cell
markers and advanced molecular technology. Two general findings from such studies have been that
(a) VZV infection of neurons is less severe, based on several criteria, than that observed in human
fibroblasts, and (b) VZV infection of neurons does not lead to apoptosis in these cells in contrast to
apoptosis observed in fibroblastic cells. Insights gained from such studies in human neural stem cells
suggest that a less severe initial lytic infection in neurons, which are resistant to apoptosis, is likely to
facilitate a pathological pathway to a latent state of the virus in human ganglia.
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1. Introduction and VZV Biology
The pathogenic human herpesvirus Varicella-Zoster virus (VZV) is neurotropic, caus-
ing varicella (chickenpox) as a primary infection is unvaccinated children. The virus then
remains in a latent state primarily in neuronal cells in several types of peripheral ganglia
throughout the nervous system including the dorsal root ganglia (DRG), cranial nerve
ganglia, particularly the trigeminal ganglia (TG), and also various autonomic ganglia
including, as recently recognised, those located in the enteric nervous system [1–3]. Fol-
lowing a variable interval of a few years to many decades, the virus may subsequently
reactivate to cause herpes zoster (shingles) which is a very painful cutaneous blistering and
dermatomally distributed rash which in some cases can be followed by the excruciatingly
painful condition known as post-herpetic neuralgia (PHN) which is typically chronic and
refractory to most treatments. While herpes zoster may reactivate spontaneously, it may
also occur after several different triggers such as malignant disease, immunosuppressant
drugs, infections, and also increasing age [2,4]. It is now recognised that not only may
VZV reactivation occur in the absence of the characteristic skin rash causing zoster sine
herpete [5,6], but also such viral reactivation may also cause a wide variety of serious neuro-
logical complications. The latter have been described in detail elsewhere [3,7] and include
encephalitis, myelitis, vasculopathy, segmental weakness and myelopathy, a variety of
cranial neuropathies, Guillain-Barre syndrome, and gastro-enteric syndromes. There is
also some evidence of the association of VZV with Giant Cell Arteritis [8] but this is a
controversial issue and, as yet, not proven [3,9]. A detailed understanding of how VZV
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interacts with human neural cells is likely to enhance our understanding of the underlying
pathogenesis of at least some of these VZV-associated neurological syndromes.
VZV has a double-stranded DNA genome the size of which is almost 125,000 base
pairs and contains 68 open reading frames (ORF), three of which are duplicated [10]. The
virus is very cell-associated and only infects human cells, in particular ganglionic neurons,
T lymphocytes and epithelial cells [2]. Due to this strong cell association, it has been
very difficult to obtain cell-free VZV in high titres, as opposed to the ease with which
this can be achieved with herpes simplex virus (HSV) [11], and this problem has been a
limiting factor in studying the VZV-neural cell interaction in vitro. VZV ganglionic latency
has been studied in some detail but there are intrinsic difficulties in investigating this
somewhat enigmatic process. Latent VZV DNA is known to be present in neurons in
a non-integrated state, being either episomal or in concatemeric form [12]. It is certain
that VZV gene transcription is limited during the latency process but the actual extent of
this gene restriction remains somewhat controversial. One of the intrinsic problems with
studying human ganglia obtained from autopsies is that the process of viral reactivation
may already have started in ganglionic neurons very soon after death of the individual.
Early studies reported the transcription of several VZV ORFs in human ganglia during
latency including VZV ORFs 29, 21 62, 63 and 66 [13–15] but these studies examined ganglia
removed up to 24 h after death raising the possibility that a degree of viral reactivation had
already occurred, a possibility that was supported by a subsequent study that reported
transcription of multiple ORFs including immediate–early, early and late genes transcribed
in such ganglionic tissues [16]. More recent evidence suggests that when the ganglia are
studied as early as less than 9 h after death, the only VZV ORF that can be detected is
VZV ORF 63 (which has always been regarded as the hallmark of VZV latency) [14,17].
However, when the interval between death and human ganglia removal was reduced even
further to about 6 h it was found that a novel unique spliced VZV transcript was detected
in latently infected human TG neurons which was found to be mapped in an antisense
configuration to the viral transactivator gene 61 [18]. Clearly VZV latency is a complex
process that requires much further investigation.
In this overview we will consider some studies of acute and persistent VZV infection
of human neural cells, focussing mainly on in vitro data. After considering some previous
reports of viral infection of mature human and animal neural cells, we will then discuss
some previous reports of VZV infection of neural stem cells. In practice these latter studies
have mainly been in cell cultures obtained by differentiating induced human pluripotent
stem cells (iPSCs), or embryonic stem cells into neurons, and these will be the main focus
of this review.
2. VZV Infection of Cultured Neural Cells
Early studies of VZV infection of cultured human neural cells relied primarily on
morphological methods of cell identification [19] as they predated the development of
cell-type specific antigenic markers for unambiguously distinguishing the different types
of human neural cells [20]. For instance, Gilden et al. [19] studied the replication of cell-free
VZV in cultures of human brain and ganglion cells and compared viral growth to that
in human fibroblasts. Descriptive assessments were made using a variety of methods
including histology, electron microscopy (EM) and virological techniques. A multifocal
cytopathic effect (cpe), including the presence of virus-specific intranuclear inclusions,
developed in all cell types after 2–3 days and VZV infection of these cells was very cell-
associated. While this study demonstrated that human neural cells were capable of being
infected by VZV, cell-type specific markers to identify the different neural cell types were
not available so the information gained was limited in this respect. A subsequent study
infected fetal DRG cultures containing both neurons and non-neuronal cells with cell-
associated VZV and did identify infected neurons using neuronal markers such as the
A2B5 monoclonal antibody and the presence of neuron-specific enolase [21]. Despite
the presence of VZV antigens (VZV glycoprotein) and a cpe observed in the identified
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neuronal cells, the latter were less susceptible to VZV-induced cytopathic damage than
the supporting non-neuronal cells. This study had the disadvantage of not using cell-free
virus but had the advantage of using double labelling immunofluorescence to identify
virus-infected neurons. This differential susceptibility of neurons and non-neuronal cells to
VZV infection has been confirmed in subsequent studies and may have relevance to VZV
ganglionic latency.
A later study of heterogeneous populations of both central and peripheral neural cell
cultures obtained from human fetal nervous tissue did used specific cell markers for both
neurons and glial cells in culture. Thus Assouline et al. [22] used cell-free VZV to infect
different heterogeneous human fetal cell cultures which contained neurons, astrocytes,
Schwann cells and fibroblasts. Neurons were identified by their expression of A2B5,
astrocytes by their cytoplasmic expression of glial acidic fibrillary protein (GFAP), and
Schwann cells by both their characteristic morphology and the expression of the nerve
growth factor (NGF) receptor. It was found that VZV replication occurred in all neural cell
types 10–16 h after infection, but virus replication was slower in neurons and Schwann cells
compared with that in astrocytes. Interestingly, there was relatively more VZV immediate–
early protein in the perinuclear cytoplasm of neurons and Schwann cells than in other cell
types suggesting the possibility of a delay in the transport of this VZV protein to its normal
nuclear location. This study again showed the relative permissiveness of non-neuronal
cells to VZV infection which could have pathogenic relevance, with astrocytes being the
most permissive cell type.
The human astrocyte was also the main focus of a later study in which the cell free
VZV OKA strain was used to infect dissociated cell cultures of human fetal brain [23]. The
cultures contained 80% glial acidic fibrillary protein (GRAP)+ (positive) astrocytes and
20% GFAP− (negative) fibroblastic cells. Using two-fluorochrome immunofluorescence, it
was shown that both a cpe and viral antigen expression (VZV immediate–early protein 62
and gpI proteins) were detected in the cells a week after infection. However, it was found
that astrocyte GFAP expression was both altered and diminished as the VZV infection
progressed indicating a downregulation of GFAP expression by the virus itself. Detailed
investigation showed that this downregulation was mediated by early rather than late
events in the viral replication cycle and did not appear to be due to virally induced shut-off
of host cell protein synthesis. These results were also observed using the multipassaged
VZV Ellen strain, and the findings were thought to possibly represent a form of biological
uncertainty phenomenon in that VZV itself was capable of modifying the result of the
actual method of identifying the cell type that is was infecting. This finding of a VZV-
mediated downregulation of GFAP was recently confirmed in an in vivo study of human
VZV encephalitis [24].
A study also indicated that VZV may have unpredictable effects in a very different
neural cell culture system which is felt to be relevant to the current discussion [25]. The aim
of the study was to investigate whether VZV obtained from patients who had developed
PHN following herpes zoster had different electrophysiological effects in a cell culture
system compared with VZV that had been isolated from patients who had not developed
PHN following zoster. VZV from both groups of patients were studied blind and were
propagated as cell-free virus. The viruses were then exposed to the ND7/23-Nav1.8
rat DRG x mouse neuroblastoma hybrid cell line which showed constitutive expression
of the exogenous Nav 1.8, and endogenous expression of Nav 1.6 and Nav 1.7 genes
which encode sodium channels known to be abnormally regulated in different forms
of neuropathic pain. Using the voltage clamp method, single cell sodium ion channel
recording was performed in the neural cell cultures after 72 h. It was found that VZV
associated with PHN increased significantly the sodium current amplitude in this cell line
compared with the non-PHN VZV, and that these findings could be abolished by exposure
of the infected cells to Tetrodotoxin (TTX). It was, therefore, concluded that the observed
PHN-associated VZV sodium current increases were mediated at least in part, by the Nav
1.6 and Nav 1.7 sodium ion channels since these are known to be blocked by TTX. While
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intriguing, the relevance of these findings to the human neurological condition is unclear
though there were clear differences in sodium channel modulation by the two groups of
isolated VZV.
3. VZV Infection of Neural Stem Cells
There are at least four reasons why knowledge of the infection of neural stem cells
may have potential importance in neurobiology and human neurological diseases. These
are (a) to gain a better understanding of the biological basis of the VZV-neuron interaction
using the various in vitro model systems, (b) they provide a mechanism of obtaining
nearly pure terminally differentiated neuronal cultures which can be investigated for their
susceptibility to viral infection, (c) they may give potential clues as to how VZV may
interact with the developing fetal nervous system with clear relevance to congenital birth
defects, and (d) they could provide a system in which to investigate the potential in vitro
efficacy of therapeutic anti-viral agents. The discussion will include both VZV infection of
embryonic neural stem cells and induced pluripotent stem cells
3.1. VZV Infection of Embryonic Neural Stem Cells
The intrinsic problems in studying VZV latency mentioned above inspired the search
for new model systems, including neuronal stem cells, induced pluripotent stem cells
(iPSCs) and neuronal organoid-like structures to make it possible to work with a human
pathogenic virus like VZV in a relevant neuronal context in vitro. However, the number
of existing neuronal stem cell derived and IPSC-derived neuronal models to study the
virological and molecular aspects of VZV infection, replication and latency is relatively
sparse, and these complex model systems remain challenging and often imperfect for
mimicking true neuronal VZV infection and latency in humans.
To provide an additional way to study the VZV-host relationship in neurons, Pugazhenti
and co-workers [26] developed an in vitro model of VZV infection of differentiated human
neural stem cells. The neurons were maintained for up to 8 weeks and were infected with
cell-free VZV (Zostavax vaccine) and expression of viral transcripts were compared to
human fetal lung fibroblasts infected with VZV. An important observation which was
consistent with previous results was that neurons were relatively resistant to apoptosis,
whereas cpe and apoptosis were induced in fibroblasts [26]. In this kind of comparative
study, it is important to expose the different cultures to an equivalent amount of virus,
since the numbers of cells may be different and the multiplicity of infection (MOI) should
always be the same.
Clearly, there are major differences between VZV infection of neuronal cells compared
to other cell types, such as fibroblasts, which is also reflected in the differences between
these tissues during the natural history of human infection with VZV, this being closely
related to the ability of VZV to be neurotropic and establish neuronal latency. Several
research groups independently have found that VZV-infected neurons remain viable for
over 2 weeks, whereas fibroblasts tend to show cpe much earlier.
Although it has been demonstrated that neurons derived from pluripotent human
embryonic stem cells (hESC) can be infected by VZV [27], it was subsequently realized
that VZV did not replicate in naïve pluripotent hESC, implying that pluripotent hESC
and neural progenitors at intermediate stages of differentiation are non-permissive for
VZV infection [28]. Since this was found to be different from HSV infection, which was
readily attainable in these more immature cells, the specific inability of VZV to infect more
premature neuronal stem cells may provide important information regarding some of the
characteristics of VZV neurotropism, latency, and intrinsic antiviral mechanisms in neurons.
Another study reported that cell-free pOka and vOka elicited productive infection spread
and release of infectious virus into the medium in hESC-derived neurons, and that the
ability to establish a productive infection was highly dependent on the MOI, rather than
on whether infection was performed with cell free or cell-associated VZV [29]. Importantly,
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such models may provide an opportunity for studying VZV reactivation and anterograde
axonal transport of relevance to the pathogenesis of zoster.
One important unresolved question in the field and also complicating in vitro studies
of VZV infection is related to VZV permissiveness in neurons and the unusual high
level of viral cell association compared to most other herpesviruses. Using hESCderived
neurons infected with cell-free wild-type VZV, it was demonstrated that neurons are highly
permissive for VZV infection, and around 100 times more permissive compared to early-
passage human embryonic lung cells or MRC-5 diploid human fibroblasts [30]. Specifically,
the authors found that since VZV grows to much higher titers in human neurons than in
other cell types, the number of total virus genomes relative to the number of viral particles
that can form plaques in culture is much lower in human neurons than in other cultured
cells. Interestingly it was also noted that neurons infected with VZV produced fewer
defective or incomplete viral particles than fibroblasts (MRC-5 cells). This led the authors
to suggest that hESC-derived neurons may be particularly useful for VZV propagation and
also that such cells represent a more optimal cell type for studying VZV neuropathogenesis
in vitro.
Some of the problems associated with working with terminally differentiated human
neurons in vitro, i.e., their slow replication, relative short life span, and heterogeneity
was addressed in a study by Goodwin et al. who described an experimental model of
normal human neural progenitor cells in tissue-like assemblies or small three- dimen-
sional organoids [31]. These organoids could be maintained for extended periods (at least
180 days) and could be infected with cell free VZV resulting in transcription of immediate
early, early and late genes with an expression profile very similar to human trigeminal
ganglia and with sporadic release of virus particles. Such models may represent physiologi-
cally relevant model systems and provide the potential for studying molecular mechanisms
and interactions involved in long term VZV infection in these “complex assemblies” of
human neuronal cells [31]. Although the model might be said to reflect permissive or
persistent infection rather than true latency, one great advantage was the long term culture
and lack of neuronal death under these experimental conditions. Collectively this system
allows for studies of infection with VZV or other neurotropic viruses in a neuronal context
with important similarities to human neuronal ganglia.
An important aspect that complicates and hampers studies and interpretation of VZV
infection of in vitro-derived neurons is that these cultures are heterogenous containing cell
types that may have different susceptibilities to VZV infection, establishment and mainte-
nance of latency, and viral reactivation [32]. Therefore, a more precise and truer picture
of VZV neuronal latency may be achieved when taking advantage of novel techniques to
investigate these mechanisms at the single cell level [32]. Finally, some recent studies using
of neurons generated from hESC were described in a study by Goldstein and colleagues
who demonstrated the expression of bioinformatically predicted viral small non-coding
RNAs, particularly microRNAs, during VZV infection [33,34]. These microRNAs are recog-
nized as important actors in modulating gene expression and have thus been suggested to
mediate an additional layer of regulation of the VZV life cycle and neuronal latency.
3.2. VZV Infection of Induced Pluripotent Stem Cells
There have been several published studies of acute VZV infection of induced pluripo-
tent stem cells (iPSCs). These cells are derived from fibroblasts which have been experi-
mentally dedifferentiated in vitro to mimic embryonic stem cells which are subsequently
induced to differentiate into neuronal cells [35]. These studies have provided particular in-
sights into the way in which VZV replicates in almost homogeneous neuronal cell cultures.
Lee et al. [36] devised a method to generate cell cultures of human sensory neurons
from iPSCs which had been originally developed from human skin fibroblasts. After
they had differentiated in culture the cells were characterised in several ways as sensory
neurons. It was found that about 80% of the total cell population expressed the neuron-
specific protein, βIII-tubulin, and 15% of the cell population co-expressed the markers
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Brn3a and peripherin, indicating that these cells were indeed sensory neurons. Their study
showed that these sensory neurons could be infected by both VZV and HSV. Interestingly,
it was found that cell-free VZV could infect human iPSC-derived sensory neurons and
neural progenitor cells, but did not infect undifferentiated iPSCs.
Subsequent studies have analysed the VZV-neuronal cell interaction in detail. Grose
et al. [37] generated highly pure (>95%) terminally differentiated neurons derived from
iPSCs and infected them with cell-free VZV. Both viral transcription and ultrastructural
features revealed by EM were investigated in these neuronal cells. It was reported that
following infection VZV glycoprotein C (gC) was not expressed in most infected neu-
rons and gC expression was markedly reduced in a minority of VZV-infected neurons
whereas expression of the early–late VZV gE glycoprotein was abundant. Transcript anal-
ysis was consistent with these findings since there was also decreased gC transcription
compared with gE. High resolution EM studies showed that in neurons there were fewer
viral particles than would be typically observed in cells productively infected with VZV.
The overall conclusion from these combined observations was that there was probably a
significant deficiency in late-phase replication and viral assembly during VZV infection of
the cultured neurons.
Another study carried out around the same time was that of Yu et al. [38] which
infected highly pure (>95%) terminally differentiated human neurons derived from iPSCs
with cell- free attenuated (vaccine strain) VZV. The neurons were confirmed as such in
virtue of their positive labelling with the neuronal marker anti-βIII tubulin. Studying
human fetal lung fibroblast cultures for comparison, these workers found that at 2 weeks
post-infection, VZV- infected neurons appeared healthy compared to the infected fibroblasts
which showed a cpe. Using molecular technology it was found that multiple regions of
the VZV genome could be detected in these non-productively infected neurons, as could
the full range of VZV transcripts and proteins. Interestingly, normal appearing infected
neurons did not contain apoptotic protein markers.
Two further studies, both published in the same year, were reported from the Col-
orado research group which provided more insights into the growth of VZV in induced
pluripotent stem cells containing almost homogenous (>95%) populations of neuronal cells.
Thus, Baird et al. [39] studied further cell-free VZV infection in the same type of induced
pluripotent stem cells as described and used in the above investigations. It was found that
there was translation of VZV proteins from all kinetic classes with the production of only
minimal infectious virus. It was also demonstrated that a low abundance of VZV DNA
was correlated with the observed failure of the virus to produce neuronal cpe. Another
study from this research group compared VZV-induced RNA transcripts in neurons and
fibroblasts [40] in attempting to account for the lack of a cpe in VZV-infected neurons
despite its presence in cultured fibroblasts derived from human fetal lung. Interestingly,
analysis of detectable VZV transcripts in neurons and fibroblasts identified only 12 dif-
ferentially transcribed genes of a total of 70 VZV ORFs, evidence that strongly suggested
that defective virus transcription is not able to explain the observed lack of cell death of
VZV-infected neurons in these cultures.
A recent study [41] also used infection of these highly pure neuronal cultures to
further investigate whether VZV infection leads to neuronal apoptosis, since an earlier
study [38] had suggested that it does not do so. Following infection with cell-free VZV it
was found that VZV DNA did not accumulate in neurons and VZV transcripts in neurons
were also only detectable at lower levels following viral infection when compared with
human fetal lung fibroblasts. When protein markers of apoptosis were analysed it was
reported that lower levels of the apoptotic marker cleaved Caspase-3 protein were detected
in VZV-infected neurons compared with the human fibroblasts, and also higher levels
of the known anti-apoptotic proteins Bcl2, Bcl-XL were found in VZV-infected neurons
compared with uninfected cells.
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4. Overall Synthesis
There are several key issues in the VZV-neural cell interaction which have been
discussed here that remain to be better understood. First, why are non-neuronal cells
such as glial cells more susceptible to acute lytic VZV infection than neurons? A clue may
be found in the recent work described by Li Puma et al. [42] where astrocytes exhibited
a higher susceptibility to HSV-1 infection than neurons, and this effect appeared to be
dependent on a higher expression of the heparan sulfate proteoglycans, a binding site
for HSV-1 located on the plasma membrane of astrocytes, and also the activation of a
GSK-3-mediated pathway leading to virus entry and replication. Since HSV-1 and VZV
share many of such features including a dependence on heparan sulphate proteoglycans
expression and the GSK-3 pathway, it is conceivable that there may be a similar biochemical
basis for the differential susceptibility to VZV observed in neuronal and glial cells. Future
studies could focus further on these aspects. Second, why do undifferentiated human
embryonic stem cells exhibit a lower degree of infection by VZV in comparison to HSV-1?
Like Dukhovny et al. [28], we are unable to provide a definite explanation for this puzzling
observation, but it may possibly be related to some kind of block to VZV infection in such
cultures and/or the intrinsic nature of the usual cell-associated infection by VZV [28]. Since
undifferentiated stem cells are generally rapidly dividing, it would be expected that viral
replication in such cells would be greater than in post-mitotic cells. It is also of interest that
undifferentiated stem cells may resemble glial cells such as radial glia [43], and that could
partially explain the greater susceptibility of stem cells to HSV-1 infection. Third, why are
neurons infected with VZV more resistant to apoptosis than non-neuronal cells? This may
be explained in part by the increased neuronal expression of anti-apoptotic proteins and
lower levels of the apoptotic marker cleaved Caspase-3 protein in VZV-infected neurons
compared to non-neuronal cells [41]. While these may reflect the result of an initial process,
it is possible that infected neurons are less susceptible to apoptotic signals designed to allow
the infected host cell to terminate itself, thereby preventing viral spread. Fourth, what is
the potential neurobiological significance of this neuronal resistance to virally induced
apoptosis? These findings, with a less severe initial lytic infection in neurons, which are
resistant to apoptosis, could potentially facilitate a pathological pathway to a latent state
of VZV in human ganglia since they allow an ongoing viral infection to occur in viable
neurons rather than an initial death of these cells which would terminate the viral infection.
Overall, many important aspects related to VZV tropism, replication, and latency
in mature neurons, IPSC-derived neurons, and neural stem cells remain incompletely
understood. Current and future studies should focus on addressing these questions using
physiologically relevant models, such as freshly isolated post-mortem human sensory
ganglia, together with investigations and comparisons of viral infection and cellular fate
in neural progenitor cells, IPSC-derived neurons, astrocytes, and glia cells. Moreover,
implementing experimental systems with neuronal three-dimensional cell assemblies or
organoids should allow studies resembling the pathophysiological processes and immune
responses occurring in human ganglia. Finally, genetic engineering by CRISPR/Cas9
technologies to modify or delete specific host genes involved in virus-cell interactions as
well as using viral mutants should provide further insights into host-pathogen interactions
in the human nervous system. Collectively, such approaches should provide deeper
insights into the cellular and viral mechanisms governing VZV infection and establishment
of latency in neurons with important parallels and relevance to VZV neuroinfection and
disease in humans.
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